Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$26.40

-0.90 (-3.28%)

As of Sep 21, 8:50 PM ET ·

ACAD vs Biotechnology Average

P/E Ratio

ACAD 12.2

Avg 29.7

Profit Margin

ACAD 36.5%

Avg -192.1%

Rev Growth

ACAD +13.8%

Avg +12.8%

Biotechnology Peers

1013 stocks in sector

Symbol	Name	Price	Change %	Market Cap	P/E	Margin	Growth	Div Yield	Analyst
ACAD	Acadia Pharmaceuticals Inc	$26.40	-3.28%	4.65B	12.2	36.5%	+13.8%	—	Current
ABBV	Abbvie Inc	$264.73	+0.29%	466.74B	74.0	6.9%	+1.8%	4.47%	Strong buy	Compare
AMGN	Amgen Inc	$392.34	+1.73%	207.25B	23.7	21.0%	+11.8%	3.21%	Hold	Compare
GILD	Gilead Sciences Inc	$151.59	+0.99%	187.10B	—	28.9%	+2.6%	3.98%	Strong buy	Compare
VRTX	Vertex Pharmaceuticals Inc	$511.29	+0.58%	130.64B	29.7	32.9%	+10.4%	—	Strong buy	Compare
REGN	Regeneron Pharmaceuticals	$794.14	+1.18%	80.58B	18.6	31.4%	+5.6%	—	Buy	Compare
MRNA	Moderna Inc	$173.40	+12.57%	63.11B	—	-145.2%	-53.4%	—	Hold	Compare
NTRA	Natera Inc	$371.40	+0.54%	52.80B	—	-9.0%	+41.1%	—	Strong buy	Compare
RVMD	Revolution Medicines Inc	$193.44	+1.30%	42.21B	—	4.4%	+0.4%	—	Strong buy	Compare
BIIB	Biogen Inc	$221.12	+2.61%	32.37B	38.8	13.1%	-0.9%	—	Buy	Compare
ALNY	Alnylam Pharmaceuticals Inc	$244.64	+2.12%	32.33B	40.0	8.5%	+53.0%	—	Strong buy	Compare
ROIV	Roivant Sciences Ltd	$39.01	-1.91%	28.53B	—	-3,629.2%	-48.7%	—	Strong buy	Compare
INSM	Insmed Inc	$121.79	+1.49%	26.21B	—	-210.5%	+35.2%	—	Strong buy	Compare
INCY	Incyte Corp	$124.79	-0.42%	25.87B	16.0	25.0%	+14.8%	—	Hold	Compare
UTHR	United Therapeutics Corp	$493.14	-0.30%	21.24B	16.2	41.9%	+18.0%	—	Strong buy	Compare
EXAS	Exact Sciences Corp	$104.91	+0.95%	20.03B	—	-6.4%	+15.9%	—	Hold	Compare
NBIX	Neurocrine Biosciences Inc	$144.31	-1.31%	15.43B	21.9	16.7%	+24.3%	—	Strong buy	Compare
EXEL	Exelixis Inc	$57.26	-1.88%	14.49B	16.8	33.7%	+12.9%	—	Hold	Compare
SMMT	Summit Therapeutics Inc	$16.90	-5.32%	14.14B	—	15.4%	-3.6%	—	Buy	Compare
BBIO	Bridgebio Pharma Inc	$66.66	+0.08%	13.16B	—	-144.4%	+86.3%	—	Strong buy	Compare
HALO	Halozyme Therapeutics Inc	$111.45	-0.89%	12.70B	30.7	22.7%	+28.4%	—	Strong buy	Compare